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Abstract 
Introduction: Venlafaxine is a prescription drug approved for the treatment of major 
depressive disorder, generalized anxiety disorder, panic disorder and social anxiety 
disorder.  It is a serotonin and norepinephrine reuptake inhibitor and a weak dopamine 
reuptake inhibitor. The aim of the present study is to investigate the in vitro effect of 
venlafaxine on human genetic material, by estimating sensitive cytogenetic indices. 
Methods: Five venlafaxine solutions (A=15μg/ml, B=30μg/ml, C=45μg/ml, 
D=60μg/ml, E=75μg/ml) were added to cultures of peripheral blood lymphocytes of 
six healthy donors. After 72 hours of incubation, the cultured lymphocytes were 
plated on glass slides, stained with the Fluorescence plus Giemsa method and Sister 
Chromatid Exchanges (SCEs), a sensitive marker of genotoxicity, Proliferation Rate 
Index (PRI), a reliable marker of cytostatic activity and Mitotic Index (MI), a marker 
which shows precisely the ability of a cell to proliferate were measured with the 
optical microscope. 
Results: Result analysis revealed t: a) a statistically significant (p=0.001) dose-
dependent increase of SCEs and b) a statistically significant (p=0.001) reduction of 
PRI and MI in all concentrations. Furthermore, a correlation was observed between a) 
SCE and PRI index variations, b) MI and SCE index variations and c) PRI and MI 
index variations.   
Conclusions: Venlafaxine exhibited dose-dependent cytogenetic activity in vitro, 
increasing SCE frequencies and diminishing PRI and MI levels in healthy human 
cultured lymphocytes. Venlafaxine as other antidepressants seems to affect human T 
lymphocytes by modifying epigenetic and DNA replication procedures. This may 
provide additional information about the mechanism of action of the drug. 
Considering that the use of venlafaxine has rapidly increased with many off label 
indications, further studies in other cell lines and in vivo experimental settings are 
needed in order to evaluate its potential effects on human genetic material. 
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Abbreviations: 
SCEs: Sister Chromatid Exchanges 
PRI: Proliferation Rate Index 
ΜΙ: Mitotic Index 
SNRI: Serotonin–Noradrenaline Reuptake Inhibitor 
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Introduction  
Nowadays, only a few new 
antidepressant drugs have been 
approved for mood disorders 
treatment. This situation leads to a 
challenging personalize treatment 
approach, concerning their use in order 
to improve efficacy and safety (van 
Westrhenen et al, 2020). Differences in 
genetic variability, environmental, 
physiological, psychological factors 
and comorbidities may alter drug 
treatment response and drug safety 
parameters (Lauschke et al, 2019). 
Furthermore, drugs like 
antidepressants, which are 
administered to a large amount of 
patients and are intended for long term 
use, should be evaluated for their 
cytogenetic behavior. Recent studies 
indicate antidepressants’ interesting 
cytogenetic behavior (Demirtzoglou et 
al. 2016, Cobanoglu et al. 2018). 
Venlafaxine is one of the most widely 
used antidepressive drugs, it is 
approved for the treatment of major 
depressive disorder, generalized 
anxiety disorder, panic disorder and 
social anxiety disorder (Warren, 2016). 
It has also been used successfully for 
chronic headaches, fibromyalgia, and 
neuropathic pain (Ayabaktı et al. 
2020). It is a serotonin–noradrenaline 
reuptake inhibitor (SNRI) and 
selectively inhibits the reuptake of both 
serotonin and noradrenaline blockers. 
This action increases the levels of 
these two neurotransmitters in the 
synapse and improves depressive 
symptoms. Despite its extended use, 
cytogenetic behavior of venlafaxine 
has not been studied extensively 
(Ayabaktı et al. 2020). 
The aim of the present study was to 
investigate the in vitro effect of 
venlafaxine on human cultured 
lymphocytes, by estimating sensitive 
cytogenetic indices, as sister chromatid 
exchanges (SCEs), proliferation rate 
index (PRI) and mitotic index (MI). 
SCEs is the exchange of genetic 
material between two identical sister 
chromatids and they appear to be the 
result of DNA-replication mistakes on 
a damaged template, probably at the 
replication fork. SCEs have been 
identified as one of the most sensitive 
indices among sensitive biomarkers of 
genotoxicity, such as chromosomal 
aberrations, comet assay and 
micronuclei. PRI and MI have been 
used as sensitive indicators for the 
evaluation of the cytostatic activity of 
various environmental hazards or 
therapeutic agents (Mourelatos, 2016).  
 
Materials and Methods 
Ethics statement 
The study was approved by the ethics 
committee of Aristotle University of 
Thessaloniki School of Medicine. 
Written informed consent was obtained 
from all individuals. 
 
Healthy Blood Donors  
Six healthy young people (3 male and 
3 female, mean age 20±2 years) were 
the blood donors.  They were non-
smokers, not receiving any drugs, not 
consuming considerable quantities of 
alcohol, or not having suffered any 
kind of infection for the last 15 days. 
No pharmacological treatment was 
taken before blood sampling. Venous 
blood collected from all above 
mentioned individuals was used 
immediately after proper preparation 
for culturing lymphocytes for the SCE, 
PRI and MI assays. 
 
In vitro SCE, PRI and MI assays. 
Human lymphocyte cultures were 
prepared by adding in 5 ml 
chromosome medium (RPMI-1640, 
Biochrome, supplemented with 20% 
fetal calf serum, 0,63% L-glutamine, 
0,63% penicillin/streptomycin and 2% 
phytohaemagglutinin) at the beginning 
of the culture life the following: 
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• 11-12 drops of heparinized whole 
peripheral blood  
• 5-Bromodeoxyuridine (BrdU) 
solution (5μg/ml/culture) and 
• Venlafaxine solution (A=15μg/ml or 
B=30μg/ml or C=45μg/ml or D=60 
μg/ml or E=75μg/ml) 
T lymphocyte cultures were incubated 
at 37o C for 72 hours in a dark 
incubator to minimize photolysis of 5 
Bromodeoxyuridine. Colchicine was 
added 2h before the end of the 
incubation. T lymphocytes were then 
collected by centrifugation and 
exposed to 0,075M KCl (potassium 
chloride) for 12 minutes. The 
hypotonic solution spreads 
chromosomes and causes hemolysis of 
red blood cells. Pellet was fixed three 
times with methanol: acetic acid (3:1). 
Drops of concentrated suspension of 
cells were placed on microslides and 
allowed to air dry. For SCE, PRI and 
MI analysis, the slides were stained by 
a modification of the fluorescence plus 
Giemsa procedure to obtain harlequin 
chromosomes (Karapidaki et al. 2011). 
 
Statistical Analysis.  
For SCE estimation, 30 suitably spread 
second division cells from each culture 
were blindly scored. For PRI 
calculation 100 cells in the first, 
second, third and higher divisions from 
each culture were blindly scored. 
PRI=M1+2M2+3M3/100, where M1, 
M2 and M3+ are the percent values of 
cells in the first, second, third and 
higher divisions, respectively. For MI 
analysis, all cell divisions that are 
present in an optical field of 1000 
nuclei were scored. MI=number of 
cells in mitosis/total number of nuclei 
(1000). The statistical analysis was 
carried out using the SPSS, vs 22.0 
statistical package. All values were 
expressed as mean ± standard error of 
the mean (SEM). Comparison of 
values between the different groups 
and subgroups was accomplished by 
the nonparametric Kruskal-Wallis test. 
It was also used for the evaluation of 
the dosage effect of venlafaxine on 
cytogenetic indices. The Spearman's 
rank correlation coefficient was 
applied for calculating the correlation 
between SCEs, PRI and MI.  
 
Results 
Table 1 summarizes the effect of 
various venlafaxine concentrations on 
the SCE index variations of T cultured 
lymphocytes (Figure 1). A statistically 
significant (p=0.001) dose-dependent 
increase on SCEs frequency due to 
venlafaxine’s effect was observed. 
Furthermore, the concentration of 
75μg/ml duplicates the SCE rate in 
cultured lymphocytes of all blood 
donors.  
Table 2 summarizes the effect of 
various venlafaxine concentrations on 
PRI index variations on T lymphocyte 
cultures (Figure 2). A significant PRI 
reduction is observed with escalating 
concentrations of venlafaxine 
(p=0.001). 
Table 3 summarizes the effect of 
various venlafaxine concentrations on 
MI index variations on T cultured 
lymphocytes (Figure 3). A significant 
MI reduction is observed with 
escalating concentrations of 
venlafaxine (p=0.001). 
Table 4 illustrates the values and 
statistical significance of correlation 
rates between SCEs, PRI and MI. 
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Table 1: Effect of venlafaxine on SCE frequency (Mean SCE/cell ±SE) in T 
lymphocyte cultures of healthy donors  
Venlafaxi
ne (μg/ml) 
Healthy  donors (n=6) 
 1 2 3 4 5 6 
Control 5.1±0.12  6.23±0.2
2 
7.31±0.2
3 
5.86±0.09 7.9±0.33 6.48±0.2
4 
15 6.8±0.20 
a 
7.45±0.1
7 a 
8.77±0.3
6 a 
7.21±0.51 a 7.05±0.26 a 8.21±0.2
1 a 
30 8.05±0.0
9 a 
9.27±0.1
1 a 
10.07±0.
13 a 
8.72±0.35 a 8.48±0.10 a 9.56±0.3
1 a 
45 9.38±0.1
7 a 
10.1±0.4
1 a 
11.23±0.
17 a 
9.89±0.31 a 11.03±0.12 a 10.65±0.
10 a 
60 10.75±0.
31a 
11.22±0.
26 a 
12.06±0.
08 a 
11.03±0.11 a 12.22±0.30 a 11.92±0.
36 a 
75 12.02±0.
19 a 
12.5±0.0
3 a 
13.87±0.
24 a 
12.88±0.22 a 13.76±0.10 a 13.44±0.
15 a 
a statistically significant (p=0.001) increase over the corresponding control (Kruskall 
Wallis test). 
 
 
 
Figure 1: Effect of Venlafaxine on SCE mean frequency in human lymphocyte 
cultures from six healthy donors 
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Table 2: Effect of venlafaxine on PRI frequency in T lymphocyte cultures of healthy 
donors 
Venlafaxine 
(μg/ml) 
Healthy  donors (n=6) 
 1 2 3 4 5 6 
Control 2,83±0.03 2,92±0.02  2,77±0.10  2,61±0.02  2,57±0.03  2,84±0.13  
15 2,32±0.07 
b 
2,41±0.02 b 2,22±0.03 
b 
2,12±0.12 
b 
2,07±0.14 
b 
2,31±0.08 b 
30 2,01±0.05 
b 
2,09±0.06 b 1,96±0.01 
b 
1,88±0.04 
b 
1,81±0.05 
b 
2±0.05 b 
45 1,8±0.02 b 1,86±0.03 b 1,79±0.03 
b 
1,62±0.06 
b 
1,6±0.05 b 1,72±0.11 b 
60 1,41±0.06 
b 
1,52±0.05 b 1,4±0.02 b 1,31±0.02 
b 
1,29±0.04 
b 
1,44±0.07 b 
p1 1,12±0.10 
b 
1,16±0.05 b 1,21±0.05 
b 
1,09±0.09 
b 
1,02±0.11 
b 
1,15±0.05 b 
b statistically significant (p=0.001) decrease over the corresponding control (Kruskall 
Wallis test). 
Figure 2: Effect of Venlafaxine on PRI mean frequency in human lymphocyte 
cultures from six healthy donors 
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Table 3: Effect of venlafaxine on MI frequency in T lymphocyte cultures of healthy 
donors 
Venlafaxine 
(μg/ml) 
Healthy  donors (n=6) 
 1 2 3 4 5 6 
Control 41±0.89 44±0.75  48±1.2 40±1.3 42±1.1 39±1.21 
15 38±0.97 
c 
39±1.01 
c 
41±0.38 
c 
37±1.04 c 37±0.88 c 37±0.45 c 
30 37±0.85 
c 
37±0.35 
c 
37±0.82 
c 
35±0.25 c 34±1.02 c 34±0.10 c 
45 36±0.50 
c 
35±1.2 c 33±0.25 
c 
34±0.12 c 33±0.10 c 32±0.26 c 
60 32±1.02 
c 
34±0.35 
c 
31±0.5 c 32±0.23 c 32±0.22 c 29±0.84 c 
75 30±1.41 
c 
32±0.65 
c 
29±0.89 
c 
30±0.45 c 31±0.11 c 28±0.09 c 
c statistically significant (p=0.001) decrease over the corresponding control (Kruskall 
Wallis test). 
 
Figure 3: Effect of Venlafaxine on MI mean frequency in human lymphocyte cultures 
from six healthy donors 
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Table 4: Correlation rates  
Correlation  Value p1 
SCEs -PRI -0.944 0.01 
SCEs -ΜΙ -0.908 0.01 
PRI -ΜΙ 0.949 0.01 
1Spearman's rho 
 
Discussion  
Antidepressive drugs offer 
symptomatic relief in mood, anxiety 
and other psychiatric disorders not 
only by acting with a single biological 
target, but also interacting with 
multiple receptors and signaling 
pathways. Venlafaxine and other 
antidepressants require a treatment 
regimen of several weeks in order to 
achieve clinical response (Witkin et al, 
2019). During this period, a lot of 
genetic and epigenetic molecular 
adaptations are taking place. However, 
human brain is difficult to access and 
study them. Evidence show that the 
hypothalamic-pituitary-adrenal axis is 
often severely disrupted in psychiatric 
disorders and inflammation has a 
crucial role in their pathophysiology 
(Leonard, 2018). Taking into 
consideration the role of T 
lymphocytes in inflammatory process 
(Rackaityte et al, 2020) and 
pathophysiology of major depressive 
disorder (Haapakoski et al, 2016), they 
can serve as an excellent in vitro model 
of genetic alterations in 
neuropsychiatric conditions.  
Evidence show that venlafaxine seem 
to effect T lymphocytes by alter 
expression of genes involving cellular 
plasticity, cytoskeleton organization 
and lymphocyte migration (Kalman et 
al, 2005). Furthermore, venlafaxine 
seems to modulate gene expression in 
ionic transport that may participate in 
the Ca2+-signal required for activation 
of lymphocytes (Kalman et al, 2005). 
Furthermore, venlafaxine seems to 
modify T lymphocyte subpopulations 
in patients with major depressive 
disorder and regulate immune system 
function (Başterzi et al, 2010). 
In the present study, the potential 
genotoxic and cytostatic effect of 
venlafaxine were evaluated using 
SCEs, PRI and MI assays in human 
cultured T lymphocytes in vitro. In 
addition, this method also has the 
advantage of testing the indices 
mentioned above in human CD4+ and 
CD8+ T lymphocyte populations. Dose 
dependent statistically significant 
SCEs induction, PRI and MI reduction 
due to venlafaxine’s effect were 
observed. A literature review shows 
that our results come in agreement 
with results of Ayabaktı et al, 2020. 
They concluded that venlafaxine has a 
potential genotoxic behavior in human 
peripheral blood lymphocytes using 
other cytogenetic indices like 
chromosome aberrations and 
cytokinesis-block micronucleus assays. 
This genotoxic behavior of venlafaxine 
does not seem to be expressed in other 
cell lines in vitro (Brambilla et al, 
2009). Other SNRIs like milnacipran 
(Yielmaz et al, 2017) and duloxetine 
(Madrigal-Bujaidar et al, 2015) also 
seem to induce DNA damage and 
express the same cytogenetic behavior 
as venlafaxine. This indicates a 
common mechanism of DNA damage 
induction by SNRIs. Mechanism of 
DNA damage expressed by SCEs 
index induction is not yet clear, but it 
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may be related to venlafaxine’s 
chemical structure (Ayabaktı et al, 
2020). Venlafaxine contains an N-
dialkyl group which have an 
intercalative ability. Another possible 
mechanism of SCEs induction is an 
insufficiency in DNA damage 
repairing by venlafaxine’s effect. Both 
DNA repair enzymes and epigenetic 
mechanisms that regulate DNA repair 
system may be involved. For instance, 
histone acetylation, one of histone 
post-translational modifications plays 
an important role in DNA damage 
response system and histone 
acetylation alterations may affect DNA 
integrity (Kim et al, 2019).  Recent 
evidence indicates that venlafaxine 
alters histone acetylation (Qiao et al, 
2019) and this can result in DNA 
damage response failure. Regarding 
the effects of venlafaxine on cell cycle 
kinetics, PRI and MI are diminished 
significantly and a strong correlation is 
observed between SCEs- PRI , SCEs-
MI and PRI-MI alterations. These 
findings come to agreement with 
CD4+ T lymphocytes level decrease 
after exposure to venlafaxine (Fazzino 
et al, 2009). Another possible 
mechanism of cytostatic induction by 
venlafaxine is epigenetic alterations 
that lead to apoptosis. For example, 
dysregulation of histone deacetylases 
can lead to cell apoptosis (Patra et al, 
2019). Finally, reactive oxygen species 
generation can induce DNA damage 
and apoptosis (Kocyigit et al, 2017), 
but venlafaxine seem to be protective 
against stress-induced oxidative DNA 
damage. 
 
Conclusions  
Taking into consideration the results of 
this study, venlafaxine shows a 
genotoxic and cytostatic cytogenetic 
behavior in vitro. In order to explicate 
these observations further studies are 
needed as cytogenetic studies in other 
cell lines (B lymphocytes, 
mononuclear cells etc) in vitro, or/and 
in vivo from patients with major 
depressive disorder as well as in 
population monitoring  
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